Carnegie Lake Advisors LLC Has $253,000 Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Carnegie Lake Advisors LLC lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,236 shares of the company’s stock after selling 125 shares during the quarter. Carnegie Lake Advisors LLC’s holdings in GE HealthCare Technologies were worth $253,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of GEHC. LGT Financial Advisors LLC grew its stake in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after buying an additional 251 shares during the last quarter. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies in the third quarter valued at approximately $26,000. Ashton Thomas Securities LLC bought a new position in shares of GE HealthCare Technologies during the third quarter worth approximately $26,000. Darwin Wealth Management LLC acquired a new stake in GE HealthCare Technologies during the 3rd quarter worth approximately $31,000. Finally, Continuum Advisory LLC boosted its stake in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.2 %

Shares of GEHC stock opened at $87.50 on Tuesday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.55. The company has a market cap of $39.98 billion, a PE ratio of 24.04, a P/E/G ratio of 2.93 and a beta of 1.15. The stock’s fifty day moving average price is $83.43 and its two-hundred day moving average price is $85.34.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Analyst Ratings Changes

A number of research firms have recently weighed in on GEHC. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $96.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.